Who
R. Loch Macdonald
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Grace Therapeutics; Chief Scientific Officer, PDS Biotechnology.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $380K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 6 Oct 2015
- Last trade
- 28 Aug 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 1 Sep 2026 | GRCE Grace Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,690 at $0.00 | filing |
| 28 Aug 2026filed 1 Sep 2026 | GRCE Grace Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,690 at $0.00 | filing |
| 14 Apr 2025filed 16 Apr 2025 | GRCE Grace Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 6 May 2024filed 8 May 2024 | GRCE Grace Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,380 at $0.00 | filing |
| 14 Jul 2023filed 18 Jul 2023 | GRCE Grace Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 15 Mar 2019filed 18 Mar 2019 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 Mar 2019filed 18 Mar 2019 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 14 Aug 2018filed 15 Aug 2018 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 19 Jun 2018filed 20 Jun 2018 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 22 Mar 2018filed 22 Mar 2018 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Sold | $41K2,500 at $16.41 | filing |
| 21 Mar 2018filed 21 Mar 2018 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Sold | $41K2,500 at $16.52 | filing |
| 20 Mar 2018filed 21 Mar 2018 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Sold | $82K5,000 at $16.47 | filing |
| 19 Mar 2018filed 21 Mar 2018 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Sold | $42K2,500 at $16.66 | filing |
| 22 Feb 2018filed 22 Feb 2018 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Sold | $36K2,500 at $14.49 | filing |
| 21 Feb 2018filed 22 Feb 2018 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Sold | $69K5,000 at $13.82 | filing |
| 20 Feb 2018filed 22 Feb 2018 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Sold | $69K5,000 at $13.75 | filing |
| 13 Mar 2017filed 15 Mar 2017 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $975K110,000 at $8.86 | filing |
| 23 Jan 2017filed 25 Jan 2017 | PDSB PDS BiotechnologyBiotechnology | SEC FORM 4 Code M | $51K25,000 at $2.04 | filing |
| 23 Jan 2017filed 25 Jan 2017 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 16 Feb 2016filed 18 Feb 2016 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.